Vaccine Adjuvants

ISBN-13: 9780896038929 / Angielski / Twarda / 2005 / 284 str.

Charles J. Hackett; Charles J. Hackett; Donald A. Harn Jr

Opis

A cutting-edge review of the major research areas of adjuvant discovery, design, development, and use. The authors lay down a rational basis for vaccine adjuvant function and analyze a number of significantly distinct adjuvant-active molecules to illuminate the principles of their function and use. The focus is on specific receptor-ligand interactions, including the molecular features needed for a compound to possess adjuvant activity. The critical interface zone between the innate and adaptive immune systems is also analyzed to show how adjuvants exert their effects on T- and B-cell activation. Additional chapters address the possibility of tailoring adjuvants to yield optimally safe and effective responses.

Recenzje

From the reviews:

"This book describes in detail major advances in vaccine adjuvant discovery, design, development, and use. ... fills a void in our knowledge of vaccine adjuvants, providing one authoritative text source for the latest information on this topic. The book meets the authors' objectives superbly. ... it could serve as a reference for students, residents, and practitioners, particularly in the fields of infectious diseases and immunology. ... It will serve as a valuable reference for those interested in this field." (Archana NMI Chatterjee, Doody's Review Service, July, 2006)

Spis treści

Microbial Pathogenesis and the Discovery of Toll-Like Receptor Function Bruce Beutler Dendritic Cells: Targets for Immune Modulation by Microbes and Immunologists Bali Pulendran, Anshu Agrawal, Stephanie Dillon, and Sudhanshu Agrawal Achieving Transcriptional Specificity in NF-kB-Dependent Inflammatory Gene Expression Gioacchino Natoli Adjuvants and the Initiation of T-Cell Responses Matthew F. Mescher, Julie M. Curtsinger, and Marc Jenkins Mechanism for Recognition of CpG DNA Kiyoshi Takeda, Hiroaki Hemmi, and Shizuo Akira CpG ODN As a Th1 Immune Enhancer for Prophylactic and Therapeutic Vaccines Arthur M. Krieg and Heather L. Davis Modified Bacterial Toxins Ed C. Lavelle, Olive Leavy, and Kingston H. G. Mills Glycosylphosphatidylinositol Anchors As Natural Immunological Adjuvants Derived From Protozoan Parasites Ricardo T. Gazzinelli, Catherine Ropert, Igor C. Almeida, João S. Silva, and Marco A. Campos The Immunomodulatory Glycan LNFPIII/Lewis X Functions As a Potent Adjuvant for Protein Antigens Mitsuhiro Okano, Kazunori Nishizaki, Akram Da'dara, Paul Thomas, Michele Carter, and Donald A. Harn, Jr. Immune and Antiviral Effects of the Synthetic Immunomodulator Murabutide: Molecular Basis and Clinical Potential George M. Bahr Effect of QS-21 on Innate and Adaptive Immune Responses Charlotte Read Kensil, Gui Liu, Christine Anderson, and James Storey Monophosphoryl Lipid A and Synthetic Lipid A Mimetics As TLR4-Based Adjuvants and Immunomodulators Jory Baldridge, Kent Myers, David Johnson, David Persing, Christopher Cluff, and Robert Hershberg Microparticles and DNA Vaccines Kimberly Denis-Mize, Manmohan Singh, Derek T. O'Hagan, Jeffrey B. Ulmer, and John J. Donnelly Index

Blurb

Recent major advances in our understanding of basic immunology have led to the development of powerful new adjuvants-substances that can stimulate the innate immune system and significantly improve the effectiveness of antigen-based vaccines. In Vaccine Adjuvants: Immunological and Clinical Principles, highly respected clinical immunologists and vaccine researchers detail the major research areas in this new era of adjuvant discovery, design, development, and use. The authors lay down a rational basis for vaccine adjuvant function and analyze a number of significantly distinct adjuvant-active molecules to illuminate the principles of their function and use. The focus is on specific receptor-ligand interactions, including the molecular features needed for a compound to possess adjuvant activity. The critical interface zone between the innate and adaptive immune systems is also analyzed to show how adjuvants exert their effects on T- and B-cell activation. Additional chapters address the possibility of tailoring adjuvants to yield optimally safe and effective responses. Among the highlights are an explanation of innate immune signaling-including Toll-like receptors-in vaccination, and a preview of emerging technologies in adjuvant research, such as microparticles and novel lipid and carbohydrate adjuvants.
Authoritative and eminently practical, Vaccine Adjuvants: Immunological and Clinical Principles moves from the basic principles of the innate immune system, through the characteristics of specific adjuvants, to detailed methods for developing the safer and more effective adjuvants that will trigger these powerful immune responses, and finally to the combinations of immune responses needed for successful vaccination.